Atypical and Dysplastic Nevi Clinical Trials

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In this presentation from the UPMC Melanoma Patient Symposium, Dr. Urvashi Mitbander Joshi, Hematology/Oncology Fellow at UPMC, provides an overview of current and emerging clinical trials focused on atypical and dysplastic nevi—moles that may carry a higher risk for melanoma development.

Dr. Joshi discusses the importance of early identification, monitoring, and participation in research aimed at understanding how these lesions evolve and how they may help inform melanoma prevention strategies. Learn about trial goals, eligibility criteria, and the potential impact of this research on patient care.

???? Presentation Highlights:

What are atypical and dysplastic nevi?

Why they matter in melanoma research

Overview of current clinical trials

How to get involved in ongoing studies

???? Presented by: Urvashi Mitbander Joshi, MD
???? Hematology/Oncology Fellow (PGY-6)
???? University of Pittsburgh Medical Center
???? Recorded at the UPMC Melanoma Patient Symposium

???? Subscribe for more updates on melanoma research, clinical trials, and patient education.

#MelanomaPrevention #ClinicalTrials #DysplasticNevi #UPMC #SkinHealth #MelanomaAwareness #DermatologyResearch
Category
Oncology
Be the first to comment

Up Next